» Articles » PMID: 38533084

Forward Genetic Screen Using a Gene-breaking Trap Approach Identifies a Novel Role of -associated RNA Transcript () in Zebrafish Heart Function

Abstract

LncRNA-based control affects cardiac pathophysiologies like myocardial infarction, coronary artery disease, hypertrophy, and myotonic muscular dystrophy. This study used a gene-break transposon (GBT) to screen zebrafish () for insertional mutagenesis. We identified three insertional mutants where the GBT captured a cardiac gene. One of the adult viable GBT mutants had bradycardia (heart arrhythmia) and enlarged cardiac chambers or hypertrophy; we named it "bigheart." Bigheart mutant insertion maps to grin2bb or N-methyl D-aspartate receptor (NMDAR2B) gene intron 2 in reverse orientation. Rapid amplification of adjacent cDNA ends analysis suggested a new insertion site transcript in the intron 2 of grin2bb. Analysis of the RNA sequencing of wild-type zebrafish heart chambers revealed a possible new transcript at the insertion site. As this putative lncRNA transcript satisfies the canonical signatures, we called this transcript . Using hybridization, we confirmed localized expression in the heart, central nervous system, and muscles in the developing embryos and wild-type adult zebrafish atrium and bulbus arteriosus. The bigheart mutant had reduced Grin2bbART expression. We showed that bigheart gene trap insertion excision reversed cardiac-specific arrhythmia and atrial hypertrophy and restored expression. Morpholino-mediated antisense downregulation of in wild-type zebrafish embryos mimicked bigheart mutants; this suggests is linked to bigheart. Cardiovascular tissues use Grin2bb as a calcium-permeable ion channel. Calcium imaging experiments performed on bigheart mutants indicated calcium mishandling in the heart. The bigheart cardiac transcriptome showed differential expression of calcium homeostasis, cardiac remodeling, and contraction genes. Western blot analysis highlighted Camk2d1 and Hdac1 overexpression. We propose that altered calcium activity due to disruption of , a putative lncRNA in bigheart, altered the Camk2d-Hdac pathway, causing heart arrhythmia and hypertrophy in zebrafish.

Citing Articles

Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine.

Angom R, Nakka N Biomedicines. 2024; 12(3).

PMID: 38540306 PMC: 10968160. DOI: 10.3390/biomedicines12030693.

References
1.
Chen Y, Pai C, Huang S, Chang S, Lin L, Chiang F . Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction. J Am Heart Assoc. 2013; 2(5):e000231. PMC: 3835223. DOI: 10.1161/JAHA.113.000231. View

2.
Kuusisto J, Karja V, Sipola P, Kholova I, Peuhkurinen K, Jaaskelainen P . Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart. 2012; 98(13):1007-13. PMC: 3368494. DOI: 10.1136/heartjnl-2011-300960. View

3.
Han P, Li W, Lin C, Yang J, Shang C, Nuernberg S . A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014; 514(7520):102-106. PMC: 4184960. DOI: 10.1038/nature13596. View

4.
Bazzini A, Johnstone T, Christiano R, Mackowiak S, Obermayer B, Fleming E . Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation. EMBO J. 2014; 33(9):981-93. PMC: 4193932. DOI: 10.1002/embj.201488411. View

5.
Zhang R, Khoo M, Wu Y, Yang Y, Grueter C, Ni G . Calmodulin kinase II inhibition protects against structural heart disease. Nat Med. 2005; 11(4):409-17. DOI: 10.1038/nm1215. View